Tsuda Y - Search Results

1

YO2 Induces Melanoma Cell Apoptosis through p53-Mediated LRP1 Downregulation.

Salama Y, Takahashi S, Tsuda Y, Okada Y, Hattori K, Heissig B. Salama Y, et al. Among authors: tsuda y. Cancers (Basel). 2022 Dec 31;15(1):288. doi: 10.3390/cancers15010288. Cancers (Basel). 2022. PMID: 36612285 Free PMC article.

2

Pharmacological targeting of plasmin prevents lethality in a murine model of macrophage activation syndrome.

Shimazu H, Munakata S, Tashiro Y, Salama Y, Dhahri D, Eiamboonsert S, Ota Y, Onoda H, Tsuda Y, Okada Y, Nakauchi H, Heissig B, Hattori K. Shimazu H, et al. Among authors: tsuda y. Blood. 2017 Jul 6;130(1):59-72. doi: 10.1182/blood-2016-09-738096. Epub 2017 Mar 21. Blood. 2017. PMID: 28325863 Free article.

3

The role of plasmin in the pathogenesis of murine multiple myeloma.

Eiamboonsert S, Salama Y, Watarai H, Dhahri D, Tsuda Y, Okada Y, Hattori K, Heissig B. Eiamboonsert S, et al. Among authors: tsuda y. Biochem Biophys Res Commun. 2017 Jun 24;488(2):387-392. doi: 10.1016/j.bbrc.2017.05.062. Epub 2017 May 10. Biochem Biophys Res Commun. 2017. PMID: 28501622

4

Inhibition of plasmin protects against colitis in mice by suppressing matrix metalloproteinase 9-mediated cytokine release from myeloid cells.

Munakata S, Tashiro Y, Nishida C, Sato A, Komiyama H, Shimazu H, Dhahri D, Salama Y, Eiamboonsert S, Takeda K, Yagita H, Tsuda Y, Okada Y, Nakauchi H, Sakamoto K, Heissig B, Hattori K. Munakata S, et al. Among authors: tsuda y. Gastroenterology. 2015 Mar;148(3):565-578.e4. doi: 10.1053/j.gastro.2014.12.001. Epub 2014 Dec 6. Gastroenterology. 2015. PMID: 25490065

5

A selective plasmin inhibitor, trans-aminomethylcyclohexanecarbonyl-L-(O-picolyl)tyrosine-octylamide (YO-2), induces thymocyte apoptosis.

Lee E, Enomoto R, Takemura K, Tsuda Y, Okada Y. Lee E, et al. Among authors: tsuda y. Biochem Pharmacol. 2002 Apr 1;63(7):1315-23. doi: 10.1016/s0006-2952(02)00866-3. Biochem Pharmacol. 2002. PMID: 11960608

6

The structure-activity relationship of various YO compounds, novel plasmin inhibitors, in the apoptosis induction.

Enomoto R, Sugahara C, Komai T, Suzuki C, Kinoshita N, Hosoda A, Yoshikawa A, Tsuda Y, Okada Y, Lee E. Enomoto R, et al. Among authors: tsuda y. Biochim Biophys Acta. 2004 Nov 1;1674(3):291-8. doi: 10.1016/j.bbagen.2004.07.004. Biochim Biophys Acta. 2004. PMID: 15541298

7

Thymocyte apoptosis induced by various compounds including YO-2 is accompanied by a change in chromatin structure.

Enomoto R, Sugahara C, Tsuda Y, Okada Y, Lee E. Enomoto R, et al. Among authors: tsuda y. Ann N Y Acad Sci. 2004 Dec;1030:622-6. doi: 10.1196/annals.1329.072. Ann N Y Acad Sci. 2004. PMID: 15659845

8

Endomorphins and related opioid peptides.

Okada Y, Tsuda Y, Bryant SD, Lazarus LH. Okada Y, et al. Among authors: tsuda y. Vitam Horm. 2002;65:257-79. doi: 10.1016/s0083-6729(02)65067-8. Vitam Horm. 2002. PMID: 12481550 Review.

9

Inhibitory effect of somatostatin Peptide analogues on DNA polymerase activity and human cancer cell proliferation.

Kuriyama I, Miyazaki A, Tsuda Y, Yokoi T, Okada Y, Takeuchi T, Sugawara F, Yoshida H, Mizushina Y. Kuriyama I, et al. Among authors: tsuda y. Anticancer Res. 2010 Dec;30(12):4841-9. Anticancer Res. 2010. PMID: 21187461

10

Developmental potential for endomorphin opioidmimetic drugs.

Okada Y, Tsuda Y, Salvadori S, Lazarus LH. Okada Y, et al. Among authors: tsuda y. Int J Med Chem. 2012;2012:715123. doi: 10.1155/2012/715123. Epub 2012 Jun 15. Int J Med Chem. 2012. PMID: 25954530 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,098 results

Search Page